Key facts
- Hims & Hers cut the top of its 2026 revenue range to $3.15 billion from $3.3 billion previously.
- The narrowed range sits below the $3.21 billion analysts expected, according to LSEG data.
- The company said gross margins contracted as it expanded into branded weight-loss drugs and international markets.
Hims & Hers Health on November 9 narrowed its 2026 revenue forecast to a range of $3.13 billion to $3.15 billion, down from a previous forecast of $3.1 billion to $3.3 billion. The new range falls below the $3.21 billion analysts expected, according to data compiled by LSEG.
The company said gross margins contracted as it expanded into branded weight-loss drugs and international markets. The forecast was reported by Reuters.